Biomeme
Immune Cell Ratio MHR

Monocyte-to-HDL Ratio

An experimental ratio pairing pro-inflammatory monocytes against anti-inflammatory HDL particles.

Primary Biological Role: Contrasts pro-atherogenic inflammatory cell counts with protective, reverse-cholesterol-transport HDL particles.

46 C

Evidence Score

Evidence Dimension Breakdown

Outcome Evidence 10/25
Assay Standardisation 14/25
Signal Specificity 11/25
Actionability & Kinetics 11/25

Overview

The Monocyte-to-HDL Cholesterol Ratio (MHR) is a hybrid metric calculated by dividing the absolute monocyte count (×10⁹/L) by high-density lipoprotein cholesterol (HDL-C in mmol/L), the convention behind the proposed NHANES reference ranges (Arabi 2025, PMID 41131556). Studies using other units produce values on a different scale, so an MHR is only comparable with ranges built the same way. It is positioned by advanced health platforms as a simultaneous assessment of pro-inflammatory vascular drive and anti-inflammatory lipid defense.

Biological Mechanism

Monocytes differentiate into tissue macrophages and ingest oxidized LDL to become foam cells within the arterial intima. HDL particles exert counter-regulatory anti-inflammatory effects by inhibiting monocyte activation, promoting endothelial repair, and facilitating reverse cholesterol transport. A high MHR reflects elevated monocyte recruitment paired with depleted HDL protection.

Clinical Trial & Outcome Evidence

In observational studies, higher MHR is associated with bare-metal stent restenosis (Yilmaz 2016, PMID 27537215) and, in NHANES, with diabetes, cardiovascular disease and disease-specific mortality (Arabi 2025, PMID 41131556).

Analytical Limitations & Confounders

Because HDL-C sits in the denominator and moves for reasons unrelated to immune activation — diet, alcohol, weight change, thyroid status, lipid-lowering therapy — any change in MHR must be decomposed into its monocyte and HDL components before it is read as a change in inflammation. HDL cholesterol concentration reflects cholesterol mass rather than HDL particle count (HDL-P) or functional efflux capacity. Monocyte differentials can vary based on automated hematology analyzer methodology. Sex-specific reference percentiles have been proposed (Arabi 2025, PMID 41131556), but no consensus clinical cutoff exists.

Kinetics & Retesting Frequency

Monocyte counts and HDL levels shift over weeks in response to dietary modifications, exercise regimens, and lipid-lowering therapies.

Frequently Asked Questions

What does the Monocyte-to-HDL Ratio measure?

MHR measures the balance between pro-inflammatory circulating monocytes (which infiltrate blood vessel walls) and protective HDL cholesterol particles.

Is MHR superior to standard lipid panels?

Not independently. MHR is a supplementary research ratio. Standard lipid markers (such as ApoB and LDL particle counts) carry far stronger prospective outcome validation.

Founding Cohort

Track Your Inflammation — Cohort Now Forming

Track your own inflammatory gene expression over time. Reserve your spot in the Inflammation Compass founding cohort today to lock in early pricing before the general public.